GlassScriptPhysician profile
John J Salvaggio
NPI 1730174673
$17,576.56
in general payments reported to CMS, 2019-2025
54 companies · $2,862 in 2025
The $2,862 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,785 · 2020: $1,600 · 2021: $3,013 · 2022: $2,897 · 2023: $2,547 · 2024: $2,872 · 2025: $2,862.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,281.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $3,789.79 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,764.67 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $1,267.83 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Amgen INC. | $1,111.87 | 2019-2025 | Evenity, Repatha, Prolia |
| Astellas Pharma US INC | $1,035.41 | 2019-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $1,013.99 | 2019-2025 | |
| Abbvie INC. | $952.88 | 2021-2025 | Ubrelvy, Linzess, Synthroid |
| Amarin Pharma, INC. | $929.49 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $678.89 | 2019-2025 | Spravato |
| Boehringer Ingelheim Pharmaceuticals, INC. | $421.70 | 2021-2025 | Jardiance |
| Dexcom, INC. | $376.34 | 2022-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $369.73 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $367.84 | 2019-2025 | Trintellix |
| Esperion Therapeutics, INC. | $292.04 | 2021-2025 | Nexletol |
| Glaxosmithkline, LLC. | $275.26 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $262.79 | 2023-2025 | Gemtesa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $224.30 | 2023-2025 | Xifaxan, Trulance |
| Abbott Laboratories | $218.25 | 2021-2025 | Freestyle Libre 3 |
| Biohaven Pharmaceutical Holding Company LTD. | $186.62 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $158.98 | 2023-2025 | Rexulti |
| Exact Sciences Corporation | $145.62 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sanofi-Aventis U.S. LLC | $137.15 | 2019-2023 | |
| Boston Scientific Corporation | $114.62 | 2022-2024 | Watchman Flx, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $105.31 | 2019-2025 | |
| Biohaven Pharmaceuticals, INC. | $100.19 | 2021 | |
| Merck Sharp & Dohme LLC | $94.12 | 2019-2021 | |
| Sanofi Pasteur INC. | $94.06 | 2019-2025 | |
| Xeris Pharmaceuticals, INC. | $83.88 | 2024-2025 | Gvoke Hypopen |
| Allergan, INC. | $83.37 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $79.52 | 2022-2023 | |
| Sunovion Pharmaceuticals INC. | $79.02 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $72.25 | 2022-2023 | Contrave, Nexlizet, Nexletol |
| Kowa Pharmaceuticals America, INC. | $63.72 | 2019-2021 | |
| Avanir Pharmaceuticals, INC. | $62.32 | 2019 | |
| Kyowa Kirin, INC. | $56.80 | 2020-2021 | |
| Eisai INC. | $51.79 | 2020-2025 | |
| Edwards Lifesciences Corporation | $45.40 | 2024-2025 | |
| Corcept Therapeutics | $42.58 | 2024-2025 | Korlym |
| E.R. Squibb & Sons, L.L.C. | $40.56 | 2023-2024 | Eliquis |
| Biosense Webster, INC. | $40.18 | 2024 | Carto 3 |
| Nevro Corp. | $36.11 | 2022 | |
| Ethicon INC. | $34.43 | 2020 | |
| Radius Health, INC. | $27.84 | 2019-2023 | Tymlos |
| Insmed, INC. | $27.32 | 2025 | Arikayce |
| Biogen, INC. | $26.05 | 2021 | |
| Si-Bone, INC. | $22.28 | 2022 | |
| Lundbeck LLC | $15.46 | 2024 | Rexulti |
| Axsome Therapeutics, INC. | $14.90 | 2025 | Symbravo |
| Teva Pharmaceuticals USA, INC. | $14.48 | 2023 | Austedo Xr |
| Arbor Pharmaceuticals, INC. | $14.43 | 2019 | |
| Almatica Pharma LLC | $13.82 | 2021 | |
| Ibsa Pharma INC. | $13.64 | 2023 | Tirosint, Licart |
| Seqirus USA INC | $13.40 | 2021 | |
| Alexion Pharmaceuticals, INC. | $11.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Salvaggio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.